Vasogen faces possible Nasdaq delisting

By Elaine Rigoli

Tampa, Fla., Aug. 11 - Vasogen, Inc. said it has received a letter from the listing qualifications department of the Nasdaq Stock Market stating that for the last 30 consecutive business days, the bid price of the company's common shares has closed below the minimum bid price of $1.00 per share requirement for continued listing.

Under Nasdaq rules, Vasogen will have six months, or until Feb. 5, 2007, to regain compliance with the bid price requirement.

The notice has no effect on the listing of Vasogen's common stock at this time, and its common stock will continue to trade on the Nasdaq Global Market under the symbol "VSGN" as well as on the Toronto Stock Exchange under the symbol "VAS."

If before Feb. 5, 2007 the bid price of Vasogen's common shares closes at $1.00 per share or more for a minimum of 10 consecutive business days, the company will regain compliance with the Marketplace Rules.

Based in Mississauga, Ont., Vasogen is a medical technology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.